Com.pl.i.t DX Liquid Breast
The assay Com.pl.i.t DX Liquid Breast has been designed for postmenopausal women with recurrent or metastatic ER+/HER2- breast cancer and is a strong indicator on whether the patient should undergo specific targeted treatments.